Liu Xuan, Wu Surui, Xu Jiao, Sui Chun, Wei Jianhe
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China.
Acta Pharm Sin B. 2017 May;7(3):292-302. doi: 10.1016/j.apsb.2017.01.002. Epub 2017 Mar 11.
The CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system was first identified in bacteria and archaea and can degrade exogenous substrates. It was developed as a gene editing technology in 2013. Over the subsequent years, it has received extensive attention owing to its easy manipulation, high efficiency, and wide application in gene mutation and transcriptional regulation in mammals and plants. The process of CRISPR/Cas is optimized constantly and its application has also expanded dramatically. Therefore, CRISPR/Cas is considered a revolutionary technology in plant biology. Here, we introduce the mechanism of the type II CRISPR/Cas called CRISPR/Cas9, update its recent advances in various applications in plants, and discuss its future prospects to provide an argument for its use in the study of medicinal plants.
CRISPR/Cas(成簇规律间隔短回文重复序列/CRISPR相关蛋白)系统最初在细菌和古生菌中被发现,能够降解外源底物。2013年它被开发成为一种基因编辑技术。在随后的几年里,由于其操作简便、效率高且在哺乳动物和植物的基因突变及转录调控方面应用广泛,受到了广泛关注。CRISPR/Cas的过程在不断优化,其应用也大幅扩展。因此,CRISPR/Cas被认为是植物生物学中的一项革命性技术。在此,我们介绍II型CRISPR/Cas即CRISPR/Cas9的作用机制,更新其在植物各种应用中的最新进展,并探讨其未来前景,为其在药用植物研究中的应用提供依据。